Swabbing Active Herpes Lesions vs. Blood Antibody Testing
When an active herpes lesion is present, PCR/NAAT testing of the lesion is definitively superior to blood antibody testing for diagnosing the current infection. 1
Why Lesion Swabbing is Superior for Active Infections
Diagnostic Performance of PCR/NAAT on Active Lesions
PCR/NAAT assays demonstrate >90% sensitivity and specificity when testing active genital ulcers or lesions, making them the gold standard for diagnosing current HSV infection 1
PCR detection rates are 11-71% superior to viral culture and vastly superior to serologic testing for active lesions 1
Type-specific differentiation is provided, allowing you to distinguish HSV-1 from HSV-2, which is critical for counseling patients about natural history and recurrence patterns 1
Critical Limitations of Blood Antibody Testing
Blood antibody tests have serious limitations that make them inappropriate for diagnosing active infections:
HSV-1 antibody tests lack sensitivity (only 70.2%), resulting in frequent false-negative results 1
HSV-2 antibody tests lack specificity (only 57.4% overall), with particularly poor performance at low index values (1.1-2.9 range shows only 39.8% specificity) 1
False-positive HSV-2 results are common in patients with HSV-1 infection, further complicating interpretation 1
Window period of up to 12 weeks means recently acquired infections will test negative on serology 1
IgM testing is unreliable, as approximately one-third of patients with recurrent HSV-2 genital herpes show IgM responses, making it a poor indicator of acute vs. chronic infection 1
When Each Test Should Be Used
Use Lesion PCR/NAAT When:
- Any active genital ulcer, vesicle, or lesion is present - this is the optimal diagnostic window 1
- Early lesions (vesicular or pustular stage) yield the highest detection rates 1
Critical Timing Caveat:
- Healing or crusted lesions may yield false-negative PCR results as viral DNA decreases during healing 1
- If PCR is negative but HSV is still suspected clinically, add serologic testing to rule out HSV-2 infection 1
Use Blood Antibody Testing When:
- No active lesions are present and you need to establish prior infection status 1
- Screening purposes or detecting newly acquired infections in asymptomatic individuals 1
- Confirming diagnosis when lesion testing was negative but clinical suspicion remains high 1
Important Serology Interpretation Rules:
- HSV-2 index values of 1.1-2.9 require confirmatory testing with a second assay (such as Biokit) before reporting positive results to patients, as specificity is only 39.8% in this range 1
- Index values ≥3.0 have better specificity (78.6%) but still warrant caution 1
- Wait 12 weeks after suspected exposure before repeating negative serology to account for the window period 1
Clinical Bottom Line
Never rely on blood antibody tests to diagnose an active herpes outbreak - the combination of poor sensitivity for HSV-1 antibodies and poor specificity for HSV-2 antibodies makes serology unreliable for this purpose 1, 2. A recent study of 299 patients with PCR-confirmed recurrent genital herpes found that combined antibody testing accuracy was only 34.9-85.7%, with many PCR-positive patients having negative serology 2. Absence of antibodies does not rule out genital herpes, and clinical assessment combined with lesion PCR remains essential 2.